Latigo Biotherapeutics Prices $345.6 Million IPO at $18 Per Share

3-line summary

• Latigo Biotherapeutics priced its IPO at $18 per share, raising $345.6 million, according to the report.

This summary is our own processing of the source article; see the source link below for full context.